EyeYon Medical develops and brings to market exclusive medical ophthalmic devices, which offer relief to unmet clinical need for millions of patients. Its innovative technologies are proven in clinical studies. EyeYon’s first product, Hyper-CL, for treating corneal edema, has received the CE Mark and FDA clearance and is approved for marketing in Europe and in the USA.EyeYon’s future product, the EndoArt is an artificial endothelial layer that cures corneal edema using an implant made of silicon film attached to the posterior corneal surface. The EndoArt is in pre-clinical stage and has demonstrated promising results in animal trials.